Following activation of the amyloid cascade, apolipoprotein e4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration

Haim Belinson, Zehavit Kariv-Inbal, Rakez Kayed, Eliezer Masliah, Daniel M. Michaelson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

According to the amyloid hypothesis, the accumulation of oligomerized amyloid-β (Aβ) is a primary event in the pathogenesis of Alzheimer's disease (AD). The trigger of the amyloid cascade and of Aβ oligomerization in sporadic AD, the most prevalent form of the disease, remains elusive. Here, we examined the hypothesis that apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for AD, triggers the accumulation of intraneuronal oligomerized Aβ following activation of the amyloid cascade. We investigated the intracellular organelles that are targeted by these processes and govern their pathological consequences. This revealed that activation of the amyloid cascade in vivo by inhibition of the Aβ degrading enzyme neprilysin specifically results in accumulation of Aβ and oligomerized Aβ and of ApoE4 in the CA1 neurons of ApoE4 mice. This was accompanied by lysosomal and mitochondrial pathology and the co-localization of Aβ, oligomerized Aβ, and ApoE4 with enlarged lysosomes and of Aβ and oligomerized Aβ with mitochondria. The time course of the lysosomal effects paralleled that of the loss of CA1 neurons, whereas the mitochondrial effects reached an earlier plateau. These findings suggest that ApoE4 potentiates the pathological effects of Aβ and the amyloid cascade by triggering the oligomerization of Aβ, which in turn, impairs intraneuronal mitochondria and lysosomes and drives neurodegeneration.

Original languageEnglish (US)
Pages (from-to)959-970
Number of pages12
JournalJournal of Alzheimer's Disease
Volume22
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Apolipoprotein E4
Amyloid
Alzheimer Disease
Lysosomes
Mitochondria
Neurons
Neprilysin
Organelles
Drive
Pathology
Enzymes

Keywords

  • Amyloid-β
  • apolipoprotein E4
  • CA1 neurons
  • lysosomes
  • mitochondria
  • neurodegeneration

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Following activation of the amyloid cascade, apolipoprotein e4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration. / Belinson, Haim; Kariv-Inbal, Zehavit; Kayed, Rakez; Masliah, Eliezer; Michaelson, Daniel M.

In: Journal of Alzheimer's Disease, Vol. 22, No. 3, 2010, p. 959-970.

Research output: Contribution to journalArticle

Belinson, Haim ; Kariv-Inbal, Zehavit ; Kayed, Rakez ; Masliah, Eliezer ; Michaelson, Daniel M. / Following activation of the amyloid cascade, apolipoprotein e4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration. In: Journal of Alzheimer's Disease. 2010 ; Vol. 22, No. 3. pp. 959-970.
@article{dd212523ddb4482f9607bd256b1c8973,
title = "Following activation of the amyloid cascade, apolipoprotein e4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration",
abstract = "According to the amyloid hypothesis, the accumulation of oligomerized amyloid-β (Aβ) is a primary event in the pathogenesis of Alzheimer's disease (AD). The trigger of the amyloid cascade and of Aβ oligomerization in sporadic AD, the most prevalent form of the disease, remains elusive. Here, we examined the hypothesis that apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for AD, triggers the accumulation of intraneuronal oligomerized Aβ following activation of the amyloid cascade. We investigated the intracellular organelles that are targeted by these processes and govern their pathological consequences. This revealed that activation of the amyloid cascade in vivo by inhibition of the Aβ degrading enzyme neprilysin specifically results in accumulation of Aβ and oligomerized Aβ and of ApoE4 in the CA1 neurons of ApoE4 mice. This was accompanied by lysosomal and mitochondrial pathology and the co-localization of Aβ, oligomerized Aβ, and ApoE4 with enlarged lysosomes and of Aβ and oligomerized Aβ with mitochondria. The time course of the lysosomal effects paralleled that of the loss of CA1 neurons, whereas the mitochondrial effects reached an earlier plateau. These findings suggest that ApoE4 potentiates the pathological effects of Aβ and the amyloid cascade by triggering the oligomerization of Aβ, which in turn, impairs intraneuronal mitochondria and lysosomes and drives neurodegeneration.",
keywords = "Amyloid-β, apolipoprotein E4, CA1 neurons, lysosomes, mitochondria, neurodegeneration",
author = "Haim Belinson and Zehavit Kariv-Inbal and Rakez Kayed and Eliezer Masliah and Michaelson, {Daniel M.}",
year = "2010",
doi = "10.3233/JAD-2010-101008",
language = "English (US)",
volume = "22",
pages = "959--970",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Following activation of the amyloid cascade, apolipoprotein e4 drives the in vivo oligomerization of amyloid-β resulting in neurodegeneration

AU - Belinson, Haim

AU - Kariv-Inbal, Zehavit

AU - Kayed, Rakez

AU - Masliah, Eliezer

AU - Michaelson, Daniel M.

PY - 2010

Y1 - 2010

N2 - According to the amyloid hypothesis, the accumulation of oligomerized amyloid-β (Aβ) is a primary event in the pathogenesis of Alzheimer's disease (AD). The trigger of the amyloid cascade and of Aβ oligomerization in sporadic AD, the most prevalent form of the disease, remains elusive. Here, we examined the hypothesis that apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for AD, triggers the accumulation of intraneuronal oligomerized Aβ following activation of the amyloid cascade. We investigated the intracellular organelles that are targeted by these processes and govern their pathological consequences. This revealed that activation of the amyloid cascade in vivo by inhibition of the Aβ degrading enzyme neprilysin specifically results in accumulation of Aβ and oligomerized Aβ and of ApoE4 in the CA1 neurons of ApoE4 mice. This was accompanied by lysosomal and mitochondrial pathology and the co-localization of Aβ, oligomerized Aβ, and ApoE4 with enlarged lysosomes and of Aβ and oligomerized Aβ with mitochondria. The time course of the lysosomal effects paralleled that of the loss of CA1 neurons, whereas the mitochondrial effects reached an earlier plateau. These findings suggest that ApoE4 potentiates the pathological effects of Aβ and the amyloid cascade by triggering the oligomerization of Aβ, which in turn, impairs intraneuronal mitochondria and lysosomes and drives neurodegeneration.

AB - According to the amyloid hypothesis, the accumulation of oligomerized amyloid-β (Aβ) is a primary event in the pathogenesis of Alzheimer's disease (AD). The trigger of the amyloid cascade and of Aβ oligomerization in sporadic AD, the most prevalent form of the disease, remains elusive. Here, we examined the hypothesis that apolipoprotein E4 (ApoE4), the most prevalent genetic risk factor for AD, triggers the accumulation of intraneuronal oligomerized Aβ following activation of the amyloid cascade. We investigated the intracellular organelles that are targeted by these processes and govern their pathological consequences. This revealed that activation of the amyloid cascade in vivo by inhibition of the Aβ degrading enzyme neprilysin specifically results in accumulation of Aβ and oligomerized Aβ and of ApoE4 in the CA1 neurons of ApoE4 mice. This was accompanied by lysosomal and mitochondrial pathology and the co-localization of Aβ, oligomerized Aβ, and ApoE4 with enlarged lysosomes and of Aβ and oligomerized Aβ with mitochondria. The time course of the lysosomal effects paralleled that of the loss of CA1 neurons, whereas the mitochondrial effects reached an earlier plateau. These findings suggest that ApoE4 potentiates the pathological effects of Aβ and the amyloid cascade by triggering the oligomerization of Aβ, which in turn, impairs intraneuronal mitochondria and lysosomes and drives neurodegeneration.

KW - Amyloid-β

KW - apolipoprotein E4

KW - CA1 neurons

KW - lysosomes

KW - mitochondria

KW - neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=78650644864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650644864&partnerID=8YFLogxK

U2 - 10.3233/JAD-2010-101008

DO - 10.3233/JAD-2010-101008

M3 - Article

C2 - 20858958

AN - SCOPUS:78650644864

VL - 22

SP - 959

EP - 970

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -